Dimitrios Kioroglou, from Oenology Faculty, is the first fellow of the Martí i Franquès COFUND Doctoral Programme to achieve the PhD Degree
Show all news from "Doctoral degrees"
The nearly zero-energy buildings (nZEB) present a promising contribution to fulfil the EU sustainable future targets. However, the construction industry that leads the development of nZEB is facing challenges to guarantee its performance. One study led by researchers from the URV in cooperation with TNO has created a diagnostic tool that uses minimal monitoring data to assess and guarantee nZEB performance
The applications are for the Martí i Franquès programme, both in its standard format and the MSCA-COFUND version, and they are from 60 and 90 different countries respectively. The individuals chosen will join the University between December this year and April 2021
All courses will be taught following a blended format and priority will be given to the face-to-face activities of first-year bachelor’s degrees
This Tuesday, 15 September, the application period was opened for both of the programme’s sections: the standard section, for which there are 45 places on offer, and COFUND, for which there are 31. The deadline for applications is 15 November 2020
Since 2014, URV has received 7.9 million euros for two projects of the COFUND-doctoral programme Marie Sklodowska-Curie Actions (MSCA)
These installations centralize large scale heating and the production of hot water. One study led by researchers from the URV has created a diagnostic tool that uses artificial intelligence to demonstrate the feasibility of these systems
The European Commission has awarded the URV’s Martí i Franquès programme more than four million euros to be used to contract 50 predoctoral researchers. The selection process will take place over two editions in 2020 and 2021, and the chosen candidates will each be awarded a three-year contract. The university will contribute a further four million euros to the project. The URV is one of three institutions in Spain to have received funding in the last call of the European Commission’s COFUND-DP programme, and it is the one that has received the most money
A study by the URV’s Cheminformatics and Nutrition research group has shown that an anti-inflammatory drug for humans and another for animals inhibit a key enzyme in the replication and transcription of the COVID-19 virus. The results of the work have been validated by the initiative COVIDMoonshot which has carried out in vitro studies and assessed their bioactivity. The results have been published in the “International Journal of Molecular Sciences”
Researchers from the NFOC-Salut group at the URV have analysed the results of the latest studies carried out in the frame of the AppleCOR project, which examines the effect of consuming anthocyanin-rich apple flesh on reducing cholesterol